This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1992 Oct 24;305(6860):1019-20.

doi: 10.1136/bmj.305.6860.1019-b.

Tachycardia during cisapride treatment

P P Humphrey, K T Bunce

PMID: 1458130
PMCID: PMC1884047
DOI: 10.1136/bmj.305.6860.1019-b

Tachycardia during cisapride treatment

P P Humphrey et al. BMJ. 1992.

. 1992 Oct 24;305(6860):1019-20.

doi: 10.1136/bmj.305.6860.1019-b.

Authors

P P Humphrey, K T Bunce

PMID: 1458130
PMCID: PMC1884047
DOI: 10.1136/bmj.305.6860.1019-b

No abstract available

PubMed Disclaimer

Similar articles

Tachycardia during cisapride treatment.
Inman W, Kubota K. Inman W, et al. BMJ. 1992 Oct 24;305(6860):1019. doi: 10.1136/bmj.305.6860.1019-a. BMJ. 1992. PMID: 1458129 Free PMC article. No abstract available.
Tachycardia during cisapride treatment.
Olsson S, Edwards IR. Olsson S, et al. BMJ. 1992 Sep 26;305(6856):748-9. doi: 10.1136/bmj.305.6856.748-a. BMJ. 1992. PMID: 1384896 Free PMC article. No abstract available.
Cardiac toxicity with cisapride.
Farrington E. Farrington E. Pediatr Nurs. 1996 May-Jun;22(3):256. Pediatr Nurs. 1996. PMID: 8717849
[A convulsive crisis in a patient with Ogilvie's syndrome treated with cisapride].
de Otero J, Borrellas X, Codinas S, Ferrer Prevosti E. de Otero J, et al. Med Clin (Barc). 1994 Feb 26;102(7):278. Med Clin (Barc). 1994. PMID: 8170222 Review. Spanish. No abstract available.
The place of cisapride in therapeutics: an interim verdict.
Hawkey CJ. Hawkey CJ. Aliment Pharmacol Ther. 1991 Aug;5(4):351-6. doi: 10.1111/j.1365-2036.1991.tb00038.x. Aliment Pharmacol Ther. 1991. PMID: 1777545 Review. No abstract available.

See all similar articles

Cited by

Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.
Perrio M, Voss S, Shakir SA. Perrio M, et al. Drug Saf. 2007;30(4):333-46. doi: 10.2165/00002018-200730040-00006. Drug Saf. 2007. PMID: 17408310
A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
Tack J, Coremans G, Janssens J. Tack J, et al. Drug Saf. 1995 Jun;12(6):384-92. doi: 10.2165/00002018-199512060-00004. Drug Saf. 1995. PMID: 8527013 Review.
Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
Wiseman LR, Faulds D. Wiseman LR, et al. Drugs. 1994 Jan;47(1):116-52. doi: 10.2165/00003495-199447010-00008. Drugs. 1994. PMID: 7510617 Review.
Drug interactions with cisapride: clinical implications.
Michalets EL, Williams CR. Michalets EL, et al. Clin Pharmacokinet. 2000 Jul;39(1):49-75. doi: 10.2165/00003088-200039010-00004. Clin Pharmacokinet. 2000. PMID: 10926350 Review.

References

1. BMJ. 1992 Sep 26;305(6856):748-9 - PubMed
1. Eur J Clin Pharmacol. 1986;30(2):205-8 - PubMed
1. Trends Pharmacol Sci. 1992 Apr;13(4):141-5 - PubMed
1. Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):403-10 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central